INX-005

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameINX-005
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionHepatitis C virus NS 5 protein inhibitors
TargetsHepatitis C virus NS 5 protein
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCardiff UniversityUniversity Of GeorgiaKu Leuven
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInhibitex Llc
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A